(1)
The Use of Rituximab in Idiopathic Inflammatory Myopathies: Description of a Monocentric Cohort and Review of the Literature. Reumatismo 2018, 70 (2), 78-84. https://doi.org/10.4081/reumatismo.2018.1011.